Loading...
Loading...
Avid Bioservices, a
subsidiary of Peregrine Pharmaceuticals, Inc.
PPHM, today
announced that it will collaborate with San Diego-based Phage
Pharmaceuticals, whereby Avid will add a custom protein production
service using Phage's novel bacteriophage production system to its
suite of current client offerings. This new service will be formally
launched at the upcoming Biotechnology Industry Organization (BIO)
International Convention from June 18-21, 2012 in Boston,
Massachusetts. Further details on the partnership were not disclosed.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in